Tysabri:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIDR201458)
◆英語タイトル:Tysabri-Drug Insights,2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIDR201458
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥113,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Tysabri:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s pharmaceuticals report, “Tysabri – Drug Insights, 2014” provides Tysabri marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


• A review of the Tysabri based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Tysabri on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Global Forecasted Sales Figure from 2011-2015
• Qualitative and quantitative assessment of market space
• SWOT Analysis

• Evaluate the marketing status and exclusivity details of Tysabri to exploit opportunities for generic drug development opportunities.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Tysabri.
• API intelligence over Tysabri and gaining primary intelligence over Active Ingredients manufacturers across the globe.
• Understanding the chemical route of synthesis of Tysabri.
• Uncovering opportunities in the rapidly growing the US market
• Stay ahead of competition by understanding the changing competitive landscape
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
• Obtain sales forecast for currently marketed drug for 2011-2015

*** レポート目次(コンテンツ)***

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Route of Synthesis
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• The Pipeline Coverage
• Clinical Trials Information
• Clinical Trials by Zone
• Company Profile
• Summary
• Company Financials
• SWOT Analysis
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

• Tysabri, Market, Global Sales (in USD), 2014
• Tysabri, Description
• Tysabri, Marketed Details the United States (US)
• Tysabri, Marketed Details the Europe (EU)
• Tysabri, Patent/Exclusivity Expiry (Year), 2014
• Tysabri, Patent Number Specific Patent Expiry (Year), 2014
• Tysabri, Patent Details
• Tysabri, Route of Synthesis
• Tysabri, the United States Drug Master File (US DMF), 2014
• Tysabri, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
• Tysabri, the API Manufacturers, China, 2014
• Tysabri, the API Manufacturers, India, 2014
• Tysabri, the API Manufacturers by the US DMF Status, 2014
• Tysabri, the API Manufacturers by Region, 2014
• Tysabri, the API Manufacturers by Location/Countries, 2014
• Tysabri, Generic Players, 2014
• Tysabri, Pipeline Drug Details, 2014
• Tysabri, Clinical Trials, 2014
• Tysabri, Clinical Trials by Zone, 2014
• Company Overview, 2014
• Tysabri, SWOT Analysis, 2014
• Phase III Pipeline Therapeutics, 2014

• Tysabri, Market, Global Sales (in million USD), 2014
• Tysabri, Global Sales % Change, 2014
• Tysabri, Patent/Exclusivity Expiry (Year), 2014
• Tysabri, Patent Number Specific Patent Expiry (Year), 2014
• Tysabri, Route of synthesis
• Tysabri, the API Manufacturers by the US DMF Status (%), 2014
• Tysabri, the API Manufacturers by Region, 2014
• Tysabri, the API Manufacturers by Location/Countries, 2014
• Tysabri, Generic Players, 2014
• Tysabri, Clinical Trials by Zone (%), 2014

*** レポートのキーワード ***

Gastrointestinal、Tysabri、医薬品、販売量、特許、医薬品有効成分(API)メーカー、治験動向 、製薬、企業

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 末梢静脈カテーテルの世界市場2016-2021
    Peripheral intravenous catheter is a sophisticated medical device widely used to deliver certain fluids, especially medicines, into a patient’s body through a vein. It is a critically important part of a medical treatment procedure that facilitates drug delivery through an intravenous route. It can …
  • ミールキット(Meal Kits)市場(~2017):イタリア
    Synopsis The report presents detailed data on consumption trends in the Meal Kits category in Italy, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers and acquisitions (of Prepared Meals …
  • 世界の測深機市場2017
    Depth Finders Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • ブリキの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Tin Plate Revenue, means the sales value of Tin Plate This report studies sales (consumption) of Tin Plate in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and …
  • 世界のヒドロキシトリプタミン市場2017
    Hydroxytryptamine Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germ …
  • 世界及び中国のcis-ジャスモン市場2016
    The 'Global and Chinese Jasmone Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Jasmone industry with a focus on the Chinese market. The report provides key statistics on the market status of the Jasmone manufacturers and is a valuable s …
  • 潰瘍(Ulcers):世界の治験レビュー(2015年上半期版)
    Ulcers Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, H1, 2015" provides an overview of Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcers. Report includes an overvi …
  • 公衆衛生管理(PHM)の北米市場予測
    KEY FINDINGSThe North America Population Health Management market was calculated to be worth $6.44 billion in 2016 and is predicted to reach $46.83 billion by 2025, owing to a CAGR growth of 24.78%. MARKET INSIGHTS The United States accounts for 40% of the world’s healthcare expenditure. Also, the i …
  • Norwegian Hull Club : 企業概要及びSWOT分析
    This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. WMI's 'Norwegian Hull Club : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are a …
  • 世界のファイバーグラスメッシュ市場2016
    2016 Global Fiber Glass Mesh Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Fiber Glass Mesh industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China) …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIDR201458 )"Tysabri:グローバル医薬品動向2014(販売量、特許、APIメーカー、治験動向など)" (英文:Tysabri-Drug Insights,2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。